198 related articles for article (PubMed ID: 30814910)
1. ITK inhibition induced in vitro and in vivo anti-tumor activity through downregulating TCR signaling pathway in malignant T cell lymphoma.
Liu Y; Wang X; Deng L; Ping L; Shi Y; Zheng W; Lin N; Wang X; Tu M; Xie Y; Liu W; Ying Z; Zhang C; Pan Z; Wang X; Ding N; Song Y; Zhu J
Cancer Cell Int; 2019; 19():32. PubMed ID: 30814910
[TBL] [Abstract][Full Text] [Related]
2. Intracellular TCR-signaling pathway: novel markers for lymphoma diagnosis and potential therapeutic targets.
Agostinelli C; Rizvi H; Paterson J; Shende V; Akarca AU; Agostini E; Fuligni F; Righi S; Spagnolo S; Piccaluga PP; Clark EA; Pileri SA; Marafioti T
Am J Surg Pathol; 2014 Oct; 38(10):1349-59. PubMed ID: 25118816
[TBL] [Abstract][Full Text] [Related]
3. ITK degradation to block T cell receptor signaling and overcome therapeutic resistance in T cell lymphomas.
Jiang B; Weinstock DM; Donovan KA; Sun HW; Wolfe A; Amaka S; Donaldson NL; Wu G; Jiang Y; Wilcox RA; Fischer ES; Gray NS; Wu W
Cell Chem Biol; 2023 Apr; 30(4):383-393.e6. PubMed ID: 37015223
[TBL] [Abstract][Full Text] [Related]
4. The retinoid derivant ECPIRM selectively exhibited anti-proliferation effects in cutaneous T-Cell lymphoma via ITK-mediated signaling pathway.
Li H; Wang C; Ma P; Zhang M; Yang H; Yuan S; Wei J; Tao L; Qian K; Xu M; Li L
J Dermatol Sci; 2020 Mar; 97(3):208-215. PubMed ID: 32165081
[TBL] [Abstract][Full Text] [Related]
5. [Follicular variant of peripheral T-cell lymphoma: a clinicopathologic and genetic study of 2 cases].
Zhan HQ; Zhu XZ; Li XQ; Zhou XY
Zhonghua Bing Li Xue Za Zhi; 2011 Jan; 40(1):32-6. PubMed ID: 21429356
[TBL] [Abstract][Full Text] [Related]
6. Novel t(5;9)(q33;q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma.
Streubel B; Vinatzer U; Willheim M; Raderer M; Chott A
Leukemia; 2006 Feb; 20(2):313-8. PubMed ID: 16341044
[TBL] [Abstract][Full Text] [Related]
7. Hierarchy of signaling thresholds downstream of the T cell receptor and the Tec kinase ITK.
Gallagher MP; Conley JM; Vangala P; Garber M; Reboldi A; Berg LJ
Proc Natl Acad Sci U S A; 2021 Aug; 118(35):. PubMed ID: 34452995
[TBL] [Abstract][Full Text] [Related]
8. Targeting interleukin-2-inducible T-cell kinase (ITK) and resting lymphocyte kinase (RLK) using a novel covalent inhibitor PRN694.
Zhong Y; Dong S; Strattan E; Ren L; Butchar JP; Thornton K; Mishra A; Porcu P; Bradshaw JM; Bisconte A; Owens TD; Verner E; Brameld KA; Funk JO; Hill RJ; Johnson AJ; Dubovsky JA
J Biol Chem; 2015 Mar; 290(10):5960-78. PubMed ID: 25593320
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive analysis of clinical, pathological, and genomic characteristics of follicular helper T-cell derived lymphomas.
Yoon SE; Cho J; Kim YJ; Ko YH; Park WY; Kim SJ; Kim WS
Exp Hematol Oncol; 2021 May; 10(1):33. PubMed ID: 33990228
[TBL] [Abstract][Full Text] [Related]
10. Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell-derived lymphomas.
Vallois D; Dobay MP; Morin RD; Lemonnier F; Missiaglia E; Juilland M; Iwaszkiewicz J; Fataccioli V; Bisig B; Roberti A; Grewal J; Bruneau J; Fabiani B; Martin A; Bonnet C; Michielin O; Jais JP; Figeac M; Bernard OA; Delorenzi M; Haioun C; Tournilhac O; Thome M; Gascoyne RD; Gaulard P; de Leval L
Blood; 2016 Sep; 128(11):1490-502. PubMed ID: 27369867
[TBL] [Abstract][Full Text] [Related]
11. The fusion kinase ITK-SYK mimics a T cell receptor signal and drives oncogenesis in conditional mouse models of peripheral T cell lymphoma.
Pechloff K; Holch J; Ferch U; Schweneker M; Brunner K; Kremer M; Sparwasser T; Quintanilla-Martinez L; Zimber-Strobl U; Streubel B; Gewies A; Peschel C; Ruland J
J Exp Med; 2010 May; 207(5):1031-44. PubMed ID: 20439541
[TBL] [Abstract][Full Text] [Related]
12. Angioimmunoblastic T-cell lymphoma contains multiple clonal T-cell populations derived from a common TET2 mutant progenitor cell.
Yao WQ; Wu F; Zhang W; Chuang SS; Thompson JS; Chen Z; Zhang SW; Clipson A; Wang M; Liu H; Bibawi H; Huang Y; Campos L; Grant JW; Wright P; Ei-Daly H; Rásó-Barnett L; Farkas L; Follows GA; Gao Z; Attygalle AD; Ashton-Key M; Liu W; Du MQ
J Pathol; 2020 Mar; 250(3):346-357. PubMed ID: 31859368
[TBL] [Abstract][Full Text] [Related]
13. Quantitative profiling of tyrosine phosphorylation revealed changes in the activity of the T cell receptor signaling pathway upon cisplatin-induced apoptosis.
Størvold GL; Landskron J; Strozynski M; Arntzen MØ; Koehler CJ; Kalland ME; Taskén K; Thiede B
J Proteomics; 2013 Oct; 91():344-57. PubMed ID: 23933134
[TBL] [Abstract][Full Text] [Related]
14. The lymphoma-associated fusion tyrosine kinase ITK-SYK requires pleckstrin homology domain-mediated membrane localization for activation and cellular transformation.
Rigby S; Huang Y; Streubel B; Chott A; Du MQ; Turner SD; Bacon CM
J Biol Chem; 2009 Sep; 284(39):26871-81. PubMed ID: 19535334
[TBL] [Abstract][Full Text] [Related]
15. Hematopoietic lineage cell-specific protein 1 is recruited to the immunological synapse by IL-2-inducible T cell kinase and regulates phospholipase Cgamma1 Microcluster dynamics during T cell spreading.
Carrizosa E; Gomez TS; Labno CM; Klos Dehring DA; Liu X; Freedman BD; Billadeau DD; Burkhardt JK
J Immunol; 2009 Dec; 183(11):7352-61. PubMed ID: 19917685
[TBL] [Abstract][Full Text] [Related]
16. IL2 Inducible T-cell Kinase, a Novel Therapeutic Target in Melanoma.
Carson CC; Moschos SJ; Edmiston SN; Darr DB; Nikolaishvili-Feinberg N; Groben PA; Zhou X; Kuan PF; Pandey S; Chan KT; Jordan JL; Hao H; Frank JS; Hopkinson DA; Gibbs DC; Alldredge VD; Parrish E; Hanna SC; Berkowitz P; Rubenstein DS; Miller CR; Bear JE; Ollila DW; Sharpless NE; Conway K; Thomas NE
Clin Cancer Res; 2015 May; 21(9):2167-76. PubMed ID: 25934889
[TBL] [Abstract][Full Text] [Related]
17. Expression of T-cell receptor signalling pathway components in extranodal NK/T-cell lymphoma.
Miyata-Takata T; Chuang SS; Takata K; Toji T; Maeda Y; Sato Y; Yoshino T
Histopathology; 2018 Dec; 73(6):1030-1038. PubMed ID: 30102799
[TBL] [Abstract][Full Text] [Related]
18. Peripheral T-cell lymphoma with follicular T-cell markers.
Rodríguez-Pinilla SM; Atienza L; Murillo C; Pérez-Rodríguez A; Montes-Moreno S; Roncador G; Pérez-Seoane C; Domínguez P; Camacho FI; Piris MA
Am J Surg Pathol; 2008 Dec; 32(12):1787-99. PubMed ID: 18779728
[TBL] [Abstract][Full Text] [Related]
19. Itk-mediated integration of T cell receptor and cytokine signaling regulates the balance between Th17 and regulatory T cells.
Gomez-Rodriguez J; Wohlfert EA; Handon R; Meylan F; Wu JZ; Anderson SM; Kirby MR; Belkaid Y; Schwartzberg PL
J Exp Med; 2014 Mar; 211(3):529-43. PubMed ID: 24534190
[TBL] [Abstract][Full Text] [Related]
20. Immune infiltration and drug specificity analysis of different subtypes based on functional status in angioimmunoblastic T-cell lymphoma.
Zhu S; Zhao Y; Xing C; Guo W; Huang Z; Zhang H; Yin L; Ruan X; Li H; Cheng Z; Wang Z; Peng H
Heliyon; 2023 Aug; 9(8):e18836. PubMed ID: 37576233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
